Table 4.
The differences in HMOD among groups
| Variables | Group A | Group B | Group C | P | P for trend |
|---|---|---|---|---|---|
| LVMI, g/m2 | 91.6 ± 27.9 | 95.2 ± 40.4* | 97.5 ± 33.7* | 0.0004 | <0.0001 |
| LVH, n (%) | 452 (28.5) | 214 (32.8) | 139 (37.7)* | 0.001 | 0.0003 |
| E/E a | 9.7 ± 3.8 | 9.8 ± 4.0 | 9.6 ± 4.3 | 0.70 | 0.81 |
| LVDD, n (%) | 232 (14.8) | 110 (17.1) | 55 (15.6) | 0.39 | 0.39 |
| CF‐PWV, m/s | 9.3 ± 2.2 | 9.6 ± 2.3* | 10.2 ± 2.6*, ** | <0.0001 | <0.0001 |
| Arterial stiffness, n (%) | 488 (31.3) | 223 (34.6) | 160 (45.2)*, ** | <0.0001 | <0.0001 |
| Carotid plaque, n (%) | 949 (59.72) | 431 (66.0)* | 283 (76.9)*, ** | <0.0001 | <0.0001 |
| GFR, mL/min/1.73 m2 | 83.1 ± 14.0 | 81.6 ± 15.9 | 77.1 ± 16.9*, ** | <0.0001 | <0.0001 |
| Renal damage, n (%) | 136 (8.5) | 75 (11.4) | 62 (16.8)*, ** | <0.0001 | <0.0001 |
Abbreviations: CF‐PWV, carotid‐femoral pulse wave velocity; E/E a, ratio of peak early diastolic transmitral flow velocity (E) and early diastolic lateral mitral annular velocity (E a); eGFR, estimated glomerular filtration rate; LVDD, left ventricular diastolic dysfunction; LVH, left ventricular hypertrophy; LVMI, left ventricular mass index.
*
P < 0.05, compared with Group A.
**
P < 0.05, compared with Group B.